223 related articles for article (PubMed ID: 10627755)
1. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch].
de Vrijer B; Harthoorn-Lasthuizen EJ; Oosterbaan HP
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2523-7. PubMed ID: 10627755
[TBL] [Abstract][Full Text] [Related]
2. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
van Dijk BA; Hirasing RA; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
[TBL] [Abstract][Full Text] [Related]
3. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
5. [Irregular blood group antibodies during pregnancy: screening is mandatory].
Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
[TBL] [Abstract][Full Text] [Related]
6. Red cell antibodies detected in antenatal tests on rhesus positive women in South and Mid Wales, 1948-1978.
Hardy J; Napier JA
Br J Obstet Gynaecol; 1981 Feb; 88(2):91-100. PubMed ID: 6779854
[TBL] [Abstract][Full Text] [Related]
7. [Blood group immunization during pregnancy in Netherlands].
Heringa MP; Waelput AJ; Flikweert S
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):454-5. PubMed ID: 10719560
[No Abstract] [Full Text] [Related]
8. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
9. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
10. [Prevention, diagnosis and treatment of blood group immunization during pregnancy].
van Aken WG; Christiaens GC
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2507-10. PubMed ID: 10627751
[TBL] [Abstract][Full Text] [Related]
11. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
12. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
Miquel E; Cavelier B; Bonneau JC; Rouger P
Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
[TBL] [Abstract][Full Text] [Related]
13. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
[TBL] [Abstract][Full Text] [Related]
14. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
[TBL] [Abstract][Full Text] [Related]
15. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
16. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
[TBL] [Abstract][Full Text] [Related]
17. [Haemolytic disease of the newborn due to anti-Duffy (author's transl)].
Schellong G; Möller B; Wagner H
Dtsch Med Wochenschr; 1974 Dec; 99(51):2610-3. PubMed ID: 4434860
[No Abstract] [Full Text] [Related]
18. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
Hendrickson JE; Delaney M
Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
[TBL] [Abstract][Full Text] [Related]
19. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
20. A case for comprehensive antenatal screening for blood group antibodies.
Anwar M; Ali N; Khattak MF; Raashid Y; Karamat KA
J Pak Med Assoc; 1999 Oct; 49(10):246-8. PubMed ID: 10647230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
